跳至主要内容
临床试验/NCT04405115
NCT04405115招募中不适用

Improving Survivorship Care for Older Adults After Chemotherapy

University of California, San Francisco2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2021年2月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
70
试验地点
2
主要终点
Number of months needed for completion of trial enrollment

研究概览

简要总结

The researchers want to find out if older adults receiving a survivorship care plan followed by a geriatric assessment visit improves quality of life and satisfaction with care compared to receiving only a survivorship care plan for older adults who have completed chemotherapy for cancer treatment.

详细描述

This study is a pilot randomized trial to examine whether a geriatric assessment-enhanced survivorship care plan improves satisfaction, knowledge and health-related quality of life compared to standard survivorship care plans among older adults who have completed curative chemotherapy for cancer. The investigator's hypothesis is that older adults who receive a geriatric assessment-enhanced survivorship care plan will report improved satisfaction with care, health-related quality of life, and knowledge and preparedness for survivorship care needs.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 65 years and above and
  • Have diagnosis of cancer and have completed chemotherapy with curative (not palliative) intent and
  • have been scheduled to receive a survivorship care plan from an oncology navigator.

排除标准

  • advanced dementia or serious cognitive impairment that would impede ability to participate in the interview
  • nursing home resident.

研究组 & 干预措施

Active comparator arm

Active Comparator

those that will be scheduled for comprehensive geriatric assessment with a geriatric nurse practitioner or physician

干预措施: Geriatric Assessment (Behavioral)

No intervention arm

No Intervention

routine care only; will not be scheduled for comprehensive geriatric assessment

结局指标

主要结局

Number of months needed for completion of trial enrollment

时间窗: 4-6 months

Acceptability of the study: survey

时间窗: 4-6 months

Assess acceptability via a short survey administered to participating oncology nurse navigators and patients selected for the intervention group.

Study retention rate

时间窗: 4-6 months

Feasibility of the study will be assessed by study retention rate which is defined as proportion of enrolled participants who remain enrolled until study completion.

次要结局

  • Patient satisfaction assessment by PSCC (Patient Satisfaction with Cancer related Care) tool(4-6 months)
  • Health related quality of life assessment by QLQ14(4-6 months)
  • Self rated patient knowledge and preparedness measured by PLANS assessment tool (Preparing for Life as a New Survivor)(4-6 months)
  • Health related quality of life assessment by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire EORTC QLQ-30(4-6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验